Article Sidebar
Views PDF: 399
PREVALENCE AND SOME FACTORS RELATED TO SARCOPENIA IN ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS
Main Article Content
Abstract
Objective: To determine the prevalence and investigate some factors related to sarcopenia in elderly patients with type 2 diabetes mellitus. Subjects and methods: research design was cross-sectional description in patients ≥ 60 years old with type 2 diabetes mellitus who visited the outpatient clinic at 175 Military Hospital from November 2019 to March 2020 with all patients who met the study inclusion criteria. Results: This study enrolled 255 patients with an average age of 76.76 ± 7.3 (age), of which the rate was 81.6% for men. The prevalence of sarcopenia in elderly patients with type 2 diabetes mellitus was 22.7%. When analyzing multivariate logistic, we recorded only duration of diabetes mellitus (OR = 0.37, 95% CI 0.14 - 0.98, p = 0.045) and body mass index (OR = 4.57, 95% CI 2.76-7.56, p <0.001) were two factors associated with sarcopenia. Conclusion: sarcopenia accounted for nearly a quarter of the elderly patients with type 2 diabetes mellitus. Diabetes duration and body mass index were two factors related to sarcopenia.
Article Details
Keywords
Sarcopenia, the elderly, type 2 diabetes mellitus
References
2. Wang T, Feng X, Zhou J, et al (2016). Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly. Scientific reports, 6.
3. Chen L. K, Liu l. K, Woo J, et al (2014). Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc, 15 (2): 95-101.
4. Maria RR, Michelangela B, Ilaria F, at el (2016). Sarcopenia in Elderly Diabetic Patients: Role of Dipeptidyl Peptidase 4 Inhibitors. JAMDA, 17: 896-901.
5. Ken S, Yasuharu T, Hiroshi I, at al (2019). Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus. J Diabetes Investig, 10: 1471–1479.
6. Tanaka S, Kamiya K, Hamazaki N, et al (2017). Utility of SARC-F for Assessing Physical Function in Elderly Patients With Cardiovascular Disease. J Am Med Dir Assoc, 18 (2): 176-181.
7. Foon YF, Yi Ling EK, Rahul M (2019). Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting. BMC Geriatrics, 19: 122.
8. Lara Bianchi, Stefano Volpato (2016). Muscle dysfunction in type 2 diabetes: a major threat to patient’s mobility and independence. Acta Diabetologic, 53: 879–889.